NDC 71335-1693 – Diphenoxylate Hydrochloride and Atropine Sulfate

Diphenoxylate Hydrochloride 2.5 mg/1; Atropine Sulfate .025 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CV

Product NDC71335-1693

Product details

Brand name
Diphenoxylate Hydrochloride and Atropine Sulfate
Generic name
Diphenoxylate hydrochloride and atropine sulfate
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA213413
Marketed since
March 15, 2020
Listing expires
December 31, 2026
Pharmacologic class
Anticholinergic; Antidiarrheal; Cholinergic Muscarinic Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Diphenoxylate Hydrochloride and Atropine Sulfate →

Package NDC codes (7)

Package NDCDescriptionSince
71335-1693-120 TABLET in 1 BOTTLE (71335-1693-1)Oct 13, 2020
71335-1693-230 TABLET in 1 BOTTLE (71335-1693-2)Dec 10, 2020
71335-1693-315 TABLET in 1 BOTTLE (71335-1693-3)Dec 29, 2021
71335-1693-410 TABLET in 1 BOTTLE (71335-1693-4)Sep 3, 2020
71335-1693-540 TABLET in 1 BOTTLE (71335-1693-5)Dec 29, 2021
71335-1693-660 TABLET in 1 BOTTLE (71335-1693-6)Dec 29, 2021
71335-1693-790 TABLET in 1 BOTTLE (71335-1693-7)Dec 29, 2021

Other Diphenoxylate Hydrochloride and Atropine Sulfate products